# L&K Bio US spinal implant market expansion

> Developing situation record from CLSTR: https://clstr.news/situations/lk-bio-us-spinal-implant-market-expansion
> Updated: 2026-11-05T00:55:10.000Z. Sources: 2. Developments: 2.

L&K Bio, through its US subsidiary L&K Spine, has initiated a business execution schedule for its spinal implant products following participation in the North American Spine Society meeting in Texas. The company has been promoting its BluEX-C cervical expandable cage, which received FDA approval in May, and reported reaching 50 cumulative cervical surgery levels in the US market.

To further its presence, L&K Biomed signed a distribution agreement with New Jersey based Precision Spine, Inc. for the BluEX-C device. This follows a previous contract with Medtronic for lumbar expandable cages. The company is also pursuing a ‘New Cervical Project’ in technical collaboration with spinal expert Dr. K. Daniel Riew to develop products for corpectomy, while collecting procedure data to develop future AI-integrated smart systems.

## Timeline

### 2026-11-05: L&K Biomed secures US distribution deal for BluEX-C cervical implants

L&K Biomed's US subsidiary signed a deal with Precision Spine to distribute BluEX-C cervical implants, expanding its footprint in the US spinal medical device market.

2 sources. https://clstr.news/cluster/lk-biomed-secures-us-distribution-deal-for-bluex-c-cervical-implants

### 2026-10-19: L&K Bio accelerates US spinal implant business via NASS 2026

L&K Bio's US subsidiary, L&K Spine, has finalized business schedules for its FDA-approved BluEX-C cervical implants following participation in the NASS 2026 conference in Texas.

3 sources. https://clstr.news/cluster/lk-bio-accelerates-us-spinal-implant-business-via-nass-2026

---
Cite as: L&K Bio US spinal implant market expansion. CLSTR, https://clstr.news/situations/lk-bio-us-spinal-implant-market-expansion